4/A

PRIMARY DOCUMENT

Company: Emmaus Life Sciences, Inc.
Filed: August 15, 2013
Period of Report: August 12, 2013
Accession Number: 0001474427-13-000009

View Document ↗ View on SEC.gov ↗